Navigation Links
Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL)
Date:4/23/2008

ucleoside inhibitor drug resistance mutations.

Data from this program are being presented by David Standring, Ph.D., executive vice president, biology, Idenix Pharmaceuticals, in an oral presentation session at 5:30 p.m. CET on Friday, April 25, 2008, and by Erika Cretton-Scott, Ph.D., director, preclinical pharmacology at Idenix Pharmaceuticals, in a poster session beginning on Thursday, April 24, 2008.

Novel Macrocyclic Protease Inhibitor Program

Based on two novel macrocyclic scaffolds, Idenix has discovered compounds that demonstrated potency with subnanomolar antiviral activity against the HCV genotype 1b NS3/4A protease target and single nanomolar activity in the HCV replicon. These compounds also displayed high selectivity in vitro with no inhibition of selected human cellular proteases. In vitro, the Idenix protease inhibitors exhibited antiviral activity against certain HCV resistant mutants associated with first-generation protease inhibitors currently in clinical development. Pharmacokinetic studies demonstrated adequate oral bioavailability and sustained liver concentrations suggesting the potential for once-daily or twice-daily dosing. Data from this program are being presented by Dr. Standring in an oral presentation session at 6:15 p.m. CET on Thursday, April 24, 2008.

"The preclinical profiles emerging in our HCV nucleoside and protease inhibitor programs are very encouraging when compared to first-generation drug candidates from both of these drug classes," said David Standring, Ph.D., executive vice president, biology, of Idenix. "We plan to have product candidates from both of these programs in clinical development within the next 12 months with the goal to evaluate our own novel combinations thereafter."

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and
'/>"/>

SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
6. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
7. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
8. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
9. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
10. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
11. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... Calif. and ST. LOUIS ... high blood pressure or high cholesterol may achieve better ... performance-based networks, according to early results of a unique ... (NASDAQ: ESRX ). "Pharmacists are one ... their frequent interactions with our members presents enormous opportunities ...
(Date:5/5/2015)... Lymphatic pump treatment (LPT) shows promise in ... a new study published in The Journal of ... performed LPT on infected rats three times a day ... to treat pneumonia. After 96 hours, over 60 percent ... 25 percent of rats who received levofloxacin alone. ...
(Date:5/5/2015)... , May 5, 2015 Big Market Research ... US, Europe , ( France , ... Spain , UK) and Japan . ... reviewed. The report provides the 5-year test volume and sales forecasts ... NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ...
Breaking Medicine Technology:SCAN Health Plan, Express Scripts' Quality Network Improves Medicare Beneficiary Health 2SCAN Health Plan, Express Scripts' Quality Network Improves Medicare Beneficiary Health 3SCAN Health Plan, Express Scripts' Quality Network Improves Medicare Beneficiary Health 4Lymphatic Pump Treatment Enhances Antibiotic Effectiveness for Treating Pneumonia 22015 Opportunities in the Global Hepatitis Diagnostic Testing Market: Big Market Research 22015 Opportunities in the Global Hepatitis Diagnostic Testing Market: Big Market Research 3
(Date:5/5/2015)... “Given that Hispanics are one in six people ... are a major step in the arsenal of facts documenting ... past 30 years, data have accumulated that the health of ... the urgency and the need to create new models of ... all,” said Jane L. Delgado, PhD, MS, President and CEO ...
(Date:5/5/2015)... The global lab automation market is expected ... in 2014, at an estimated CAGR of 6.7% from ... market on the basis of equipment and software, application, ... basis of application, Lab Automation Market is classified into ... Drug discovery is a major application of the lab ...
(Date:5/5/2015)... 05, 2015 The newly minted Regan Arts has ... Dr. Brad Reedy from his 20 years working in ... why she chose to publish a parenting book and why this ... publisher) is the idea that it is a journey, not a ... are on the trek sometimes together and sometimes not...that each of ...
(Date:5/5/2015)... Skedans Systems a division of ... Sensor Collaboration Platform at AUVSI's Unmanned Systems 2015 ... provides tooling to deliver real time information for decision ... Sensor Collaboration Platform is a single unified cloud software ... Web Real Time Communications (WebRTC), and commercial Unmanned Autonomous ...
(Date:5/5/2015)... 05, 2015 Information Innovators ... serving the federal government, today announced its acquisition ... CCSi provides solutions exclusively to federal government customers ... in cyber security, health services, and program management ... industry-relevant credentials as a Third Party Assessment Organization ...
Breaking Medicine News(10 mins):Health News:“Its about time,” Declares the National Alliance for Hispanic Health on First CDC Study of Hispanic Health 2Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 2Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 3Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 4Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 5Health News:The Last Parenting Book You Will Ever Need: Veteran Publisher Judith Regan Releases A Provocative New Book By Dr. Brad Reedy, "The Journey Of The Heroic Parent" 2Health News:The Last Parenting Book You Will Ever Need: Veteran Publisher Judith Regan Releases A Provocative New Book By Dr. Brad Reedy, "The Journey Of The Heroic Parent" 3Health News:Skedans Systems Announces Skedans Sensor Collaboration Platform at AUVSI's Unmanned Systems 2015 in Atlanta 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 3Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 4
... 5, 2008 The American Cancer Society, the American ... Force on Colorectal Cancer (a group that comprises ... Gastroenterological Association, and American Society for Gastrointestinal Endoscopy) ... colorectal cancer screening. The guidelines add two new ...
... child,has a chronic illness is never easy, especially when ... it comes to physical,activities for children, most parents prefer ... experts say that may be a mistake. The spring ... Lupus Now(R), reports,that once a child,s lupus has been ...
... 5 Relax The Back corporation,sold a record number ... 16 franchised locations were sold last year, and 12 ... to deliver similarly,strong franchise sales results, with four stores ... another nine scheduled to open by June. The,company,s long-term ...
... Biopharmaceuticals using innovative technology in study of ... anti-infective ... today announced it has achieved another major milestone,in the management of ... The milestone EDC trial is a Phase II study being ...
... who rely on Community and Mission Hospital of Huntington ... go elsewhere as the,facility shuts its doors., The ... Mission. No new patients will be admitted and about ... its urgent care operations,last year., The Huntington Park ...
... decode the mind for therapeutic purposes , , WEDNESDAY, March 5 ... report they have found a way to "read" visual activity ... to scan the brain for activity information related to the ... of brain activity-image links is then created, so that future ...
Cached Medicine News:Health News:Health groups issue updated colorectal cancer screening guidelines 2Health News:Health groups issue updated colorectal cancer screening guidelines 3Health News:Child's Play - Lupus Now(R) Magazine Explores Activities for Children With a Chronic Condition 2Health News:Relax The Back Announces Record Growth in 2007; Executives Bullish on Specialty Retailer's Prospects for 2008 2Health News:Quintiles Data Management Surpasses 300 EDC Trials 2Health News:Community & Mission Hospital of Huntington Park Shutting Down Mission Campus, Terminating Workers 2Health News:Brain Scans Let Computer 'Read' Visual Activity 2Health News:Brain Scans Let Computer 'Read' Visual Activity 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: